SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-055630
Filing Date
2023-11-16
Accepted
2023-11-16 20:39:16
Documents
2
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7490
2 POA DOCUMENT poa.txt EX-24 2837
  Complete submission text file 0001209191-23-055630.txt   11847
Mailing Address DAY ONE BIOPHARMACEUTICALS, INC. 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address
Dubow Adam (Reporting) CIK: 0001744507 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40431 | Film No.: 231416181

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations